Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273 : a randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)

Bron
International journal of infectious diseases - ISSN 1201-9712-146 (2024) p. 1-11
Auteur(s)
    Jannik Stemler, Lusine Yeghiazaryan, Christoph Stephan, Kristin Greve-Isdahl Mohn, Antonio-José Carcas-Sansuan, Esperanza Romero Rodriguez, José Moltó, Itziar Vergara Mitxeltorena, Tobias Welte, Birutė Zablockienė, Murat Akova, Ullrich Bethe, Sarah Heringer, Jon Salmanton-García, Julia Jeck, Lea Tischmann, Marouan Zarrouk, Arnd Cüppers, Lena M. Biehl, Jan Grothe, Sibylle C. Mellinghoff, Julia A. Nacov, Julia M. Neuhann, Rosanne Sprute, Jesús Frías-Iniesta, Riya Negi, Colette Gaillard, Gurvin Saini, Alejandro García León, Patrick W.G. Mallon, Christine Lammens, An Hotterbeekx, Katherine Loens, Surbhi Malhotra, Herman Goossens, Samir Kumar-Singh, Franz König, Martin Posch, Philipp Koehler, Oliver A. Cornely

Interleukin‐2‐mediated CD4 T‐cell activation correlates highly with effective serological and T‐cell responses to SARS‐CoV‐2 vaccination in people living with HIV

Bron
Journal of medical virology - ISSN 0146-6615-96:8 (2024) p. 1-14
Auteur(s)

High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients

Bron
Journal of medical virology - ISSN 0146-6615-95:11 (2023) p. 1-6
Auteur(s)
    Houssem Redha Chenane, Guillaume Lingas, Reyene Menidjel, Cedric Laouenan, Sarah Tubiana, Diane Descamps, Quentin Le Hingrat, Laurent Abel, Jeremie Guedj, Surbhi Malhotra, Samir Kumar-Singh, Benoit Visseaux, Jade Ghosn, Charlotte Charpentier, Samuel Lebourgeois